AngioDynamics, Inc.
ANGO
NASDAQ·Healthcare·Medical - Instruments & Supplies·Mkt cap $628.3M
$15.20
▼ -1.75%
P/E
-17.27
Mkt Cap
$628.3M
52-Wk Range
$9.39–$16.29
52-Week Range
$9.39 - $16.29
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 39.5% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary NanoKnife irreversible electroporation technology with limited direct competition
- Comprehensive vascular access portfolio addressing multiple clinical settings and patient populations
- Established relationships with interventional specialists and direct sales force in key markets
- Diversified product mix across oncology, vascular, and critical care reducing market concentration risk
Bear Case
1 risk
- Low volatility (beta 0.3).
Growth
Stable outlook
Rising cancer incidence driving demand for minimally invasive ablation therapies
Value
Deep value opportunity - significant discount to Medical Devices peers
Momentum
Hot
+27.4% over 3m
Quality
Strong
Strong fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying ANGO right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Oct 1, 2026
JUL 14, 2026
Reported EPS of -$0.07 vs -$0.11 consensus (+36.4% surprise). Revenue of $86.6M vs $80.2M expected (+7.9%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+36.4%
Revenue trend · last 8Q
—
—
-4%
+13%
+12%
+9%
+9%
+8%
Q1 24
Q2 24
Q3 25
Q4 25
Q1 25
Q2 25
Q3 26
Q4 26
$67.5M
$72.8M
$72.0M
$80.2M
$75.7M
$79.4M
$78.4M
$86.6M
Margins · last 8Q
Gross
57.1%
Operating
-23.5%
Profit
-13.2%
Wall Street consensus
2 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: HC Wainwright · Jul 15, 2026
vs Industry
How ANGO stacks vs Medical - Instruments & Supplies
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related